It is under investigation in preclinical and clinical studies on overweight, obesity, and metabolic disorders, where researchers have examined its effects on body weight and energy intake, including when combined with GLP 1 receptor agonists such as semaglutide, but it is not an approved therapy
Randomized controlled trials (RCTs) report that IF reduces androgen markers, including total testosterone and free androgen index, in premenopausal females with obesity, while producing modest declines in testosterone among lean males without significantly affecting LH secretion [55]
Understanding BPC-157 BPC-157 is a synthetic peptide known for its potential healing and regenerative properties
It has also shown to help reduce fatigue and body aches from autoimmune disease
The integration of continuous glucose monitors (CGM) with peptide therapy allows real-time feedback on metabolic responses
$450.00 $2,600.00 HEALING & REPAIR $165.00
